VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SLABSilicon Laboratories Inc.
$218.42$7.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksSLABFinancials

Silicon Laboratories Inc. (SLAB) Financials

27Y historyFree accessUpdated daily

Revenue growth has accelerated to 20.1% in 2026Q1, though the company continues to struggle with operating leverage as evidenced by a persistent -2.8% operating margin.

SLAB Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMJan'26Dec'24Dec'23Dec'22Jan'22Jan'21Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99
Sales/Revenue820.55M784.76M584.39M782.26M1.02B720.86M510.93M473.79M868.27M768.87M697.63M644.83M620.7M580.09M563.29M491.63M493.34M441.02M415.63M337.46M464.6M425.69M456.23M325.31M182.02M74.06M103.1M46.9M
Revenue Growth %25.14%34.29%-25.3%-23.62%42.07%41.09%7.84%-45.43%12.93%10.21%8.19%3.89%7%2.98%14.58%-0.35%11.86%6.11%23.16%-27.36%9.14%-6.69%40.25%78.72%145.75%-28.16%119.84%-
Cost of Goods Sold340.39M327.78M272.2M321.67M381.55M295.47M216.08M193.57M346.87M314.68M276.12M264.06M242.15M227.18M225.28M193.18M169.1M161.27M159.84M130.22M208.22M193.9M206.23M162.17M79.94M31.93M28.84M13.6M
COGS % of Revenue-41.77%46.58%41.12%37.26%40.99%42.29%40.86%39.95%40.93%39.58%40.95%39.01%39.16%39.99%39.29%34.28%36.57%38.46%38.59%44.82%45.55%45.2%49.85%43.92%43.11%27.97%29%
Gross Profit480.16M456.98M312.19M460.59M642.56M425.39M294.85M280.21M521.4M454.19M421.5M380.77M378.55M352.9M338.02M298.45M324.24M279.75M255.78M207.24M256.38M231.78M250M163.13M102.08M42.13M74.27M33.3M
Gross Margin %58.52%58.23%53.42%58.88%62.74%59.01%57.71%59.14%60.05%59.07%60.42%59.05%60.99%60.84%60.01%60.71%65.72%63.43%61.54%61.41%55.18%54.45%54.8%50.15%56.08%56.89%72.03%71%
Gross Profit Growth %-46.38%-32.22%-28.32%51.05%44.28%5.22%-46.26%14.8%7.75%10.7%0.59%7.27%4.4%13.26%-7.96%15.9%9.37%23.43%-19.17%10.61%-7.28%53.25%59.81%142.26%-43.27%123.03%-
Operating Expenses524.5M527.52M477.68M484.74M523.3M458.23M401.93M368.86M436.19M369.22M355.23M348.54M327.13M288.59M252.34M248.37M237.57M213.24M201.88M184.14M224.06M173.78M143.31M96.12M71.05M93.38M50.9M18.6M
OpEx % of Revenue-67.22%81.74%61.97%51.1%63.57%78.67%77.85%50.24%48.02%50.92%54.05%52.7%49.75%44.8%50.52%48.16%48.35%48.57%54.57%48.23%40.82%31.41%29.55%39.04%126.08%49.37%39.66%
Selling, General & Admin176.93M174.28M145.45M147M190.97M185.02M166.75M163.17M197.84M159.73M155.48M160.49M154.15M130.79M114.39M112.42M113.75M108.85M100.67M94.82M102.36M72.55M64.16M42.84M33.88M20.06M17.65M7.2M
SG&A % of Revenue-22.21%24.89%18.79%18.65%25.67%32.64%34.44%22.79%20.77%22.29%24.89%24.83%22.55%20.31%22.87%23.06%24.68%24.22%28.1%22.03%17.04%14.06%13.17%18.61%27.08%17.12%15.35%
Research & Development347.57M353.25M332.23M337.74M332.33M273.21M235.19M205.69M238.35M209.49M199.74M188.05M172.99M157.8M137.95M135.95M123.82M104.39M101.2M89.32M121.71M101.22M74.92M48.3M32M28.98M19.42M8.3M
R&D % of Revenue-45.01%56.85%43.18%32.45%37.9%46.03%43.41%27.45%27.25%28.63%29.16%27.87%27.2%24.49%27.65%25.1%23.67%24.35%26.47%26.2%23.78%16.42%14.85%17.58%39.13%18.83%17.7%
Other Operating Expenses0000000000-485K127K-234K157K484K00000004.24M4.99M5.17M44.35M13.83M3.1M
Operating Income-44.34M-70.54M-165.49M-24.15M119.26M-32.84M-107.09M-88.64M85.21M84.97M66.28M32.23M51.42M64.31M85.67M50.07M86.67M66.51M43.66M23.1M29.11M58.01M106.69M65.41M31.03M-51.25M23.37M14.7M
Operating Margin %-5.4%-8.99%-28.32%-3.09%11.65%-4.56%-20.96%-18.71%9.81%11.05%9.5%5%8.28%11.09%15.21%10.19%17.57%15.08%10.5%6.84%6.27%13.63%23.38%20.11%17.05%-69.19%22.66%31.34%
Operating Income Growth %-57.37%-585.15%-120.25%463.18%69.34%-20.81%-204.03%0.28%28.21%105.61%-37.31%-20.04%-24.94%71.1%-42.23%30.31%52.35%89.01%-20.67%-49.81%-45.63%63.09%110.84%160.54%-319.31%58.96%-
EBITDA-9.6M-32.46M-116.91M26.93M175.85M29.72M-48.25M-35.72M139.12M126.84M106.79M73.88M81.91M93.71M113.45M74.67M105.96M86.24M62.28M39.18M50.35M78.54M130.43M89.57M48.61M-33.07M37.2M17.8M
EBITDA Margin %-1.17%-4.14%-20%3.44%17.17%4.12%-9.44%-7.54%16.02%16.5%15.31%11.46%13.2%16.15%20.14%15.19%21.48%19.55%14.98%11.61%10.84%18.45%28.59%27.53%26.71%-44.65%36.08%37.95%
EBITDA Growth %89.44%72.24%-534.16%-84.69%491.75%161.59%-35.1%-125.67%9.68%18.77%44.55%-9.8%-12.6%-17.4%51.93%-29.53%22.87%38.47%58.95%-22.18%-35.9%-39.78%45.62%84.25%246.99%-188.9%108.99%-
D&A (Non-Cash Add-back)34.74M38.09M48.59M51.08M56.59M62.56M58.84M52.93M53.91M41.87M40.52M41.65M30.48M29.4M27.77M24.6M19.29M19.73M18.62M16.09M21.23M20.53M23.74M24.16M17.59M18.17M13.83M3.1M
EBIT-34.76M-56.94M-153.5M-4.99M133.18M-27.14M-98.06M-75.78M91.86M92.84M66.83M33.09M52.19M65.32M87.5M52.38M87.74M69.15M53.55M23.1M8.65M65.96M111.89M67.01M31.03M-51.25M23.37M14.7M
Net Interest Income8.89M12.63M10.68M13.61M7.19M-25.34M-25.11M-7.37M-13.05M-8.07M-1.78M-1.97M-2.15M-2.44M189K1.82M2.24M2.54M10.02M0000-1.59M0000
Interest Income9.81M13.6M11.99M19.16M13.91M5.7M9.03M12.87M6.65M6.06M1.29M730K1.01M853K1.34M1.86M2.32M2.73M10.45M00001.37M0000
Interest Expense923K975K1.31M5.55M6.72M31.03M34.14M20.23M19.69M14.13M2.59M2.83M3.15M3.29M1.15M37K77K180K11.6M00002.96M403K32.01M0400K
Other Income/Expense1.31M12.63M10.68M-2.42M10.59M-11.61M-23M-7.37M-13.05M-8.07M-1.78M-1.97M-2.38M-2.28M673K2.27M988K2.46M9.46M23.43M13.62M7.63M4.89M782K281K2.87M2.48M-400K
Pretax Income-43.03M-57.91M-154.81M-26.57M129.85M-44.45M-130.09M-96.01M72.16M76.9M64.5M30.26M49.04M62.03M86.35M52.34M87.66M68.97M53.12M46.52M42.73M65.64M111.58M66.2M31.31M-48.38M25.85M14.3M
Pretax Margin %-5.24%-7.38%-26.49%-3.4%12.68%-6.17%-25.46%-20.26%8.31%10%9.25%4.69%7.9%10.69%15.33%10.65%17.77%15.64%12.78%13.79%9.2%15.42%24.46%20.35%17.2%-65.32%25.07%30.49%
Income Tax7.3M7M36.2M7.94M38.45M13.43M-14.6M6.98M-11.43M29.81M3M677K11.02M12.21M22.8M16.87M14.42M-4.13M20.18M6.84M11.57M18.14M34.88M21.48M10.59M-2.8M11.83M3.3M
Effective Tax Rate %-16.98%-12.08%-23.38%-29.89%29.61%-30.21%11.22%-7.27%-15.84%38.76%4.65%2.24%22.47%19.68%26.4%32.23%16.45%-5.98%37.99%14.7%27.09%27.63%31.26%32.45%33.83%5.79%45.77%23.08%
Net Income-50.33M-64.91M-191.01M-34.52M91.4M2.12B12.53M19.27M83.59M47.09M61.49M29.59M38.02M49.82M63.55M35.47M73.24M73.09M32.94M204.84M31.16M47.51M76.69M44.72M20.72M-45.57M14.02M11M
Net Margin %-6.13%-8.27%-32.69%-4.41%8.93%293.73%2.45%4.07%9.63%6.12%8.81%4.59%6.13%8.59%11.28%7.22%14.85%16.57%7.92%60.7%6.71%11.16%16.81%13.75%11.38%-61.53%13.6%23.45%
Net Income Growth %69.49%66.02%-453.4%-137.76%-95.68%16797.29%-34.95%-76.95%77.51%-23.42%107.85%-22.19%-23.68%-21.6%79.15%-51.57%0.21%121.93%-83.92%557.41%-34.41%-38.06%71.51%115.84%145.46%-425.13%27.43%-
Net Income (Continuing)-50.33M-64.91M-191.01M-34.52M91.4M-57.87M-115.48M-102.67M83.59M47.09M61.49M29.59M38.02M49.82M63.55M35.47M73.24M73.09M32.94M39.69M15.34M17.7M76.69M44.72M20.72M-45.57M14.02M11M
Discontinued Operations000002.18B128.02M121.94M00000000000165.15M15.81M0000000
Minority Interest0000000000000000000000000000
EPS (Diluted)-1.53-1.98-5.93-1.092.5447.780.280.441.901.091.450.690.871.141.470.791.571.570.673.640.540.320.580.860.41-0.990.290.25
EPS Growth %70.03%66.61%-444.04%-142.91%-94.68%16964.29%-36.36%-76.84%74.31%-24.83%110.14%-20.69%-23.68%-22.45%86.08%-49.68%0%134.33%-81.59%574.07%68.75%-44.83%-32.56%109.76%141.41%-441.38%16%-
EPS (Basic)--1.98-5.93-1.092.6149.440.290.441.941.111.470.700.881.171.510.821.631.620.683.740.560.330.620.920.44-0.990.370.73
Diluted Shares Outstanding32.96M32.72M32.19M31.8M36.04M44.31M44.37M44.29M44.04M43.33M42.38M42.95M43.79M43.54M43.11M44.83M46.74M46.54M48.99M56.32M57.2M55.24M54.93M52.29M50.81M45.91M48.79M43.66M
Basic Shares Outstanding32.96M32.72M32.19M31.8M35.09M42.83M43.77M43.35M43.16M42.45M41.71M42.31M42.97M42.72M42.14M43.42M44.84M45.02M48.11M54.83M55.35M53.13M51.12M48.85M47.42M45.91M38.33M15.15M
Dividend Payout Ratio----------------------------

Key Metrics

Growth RegimeAccelerating
ProfitabilityNegative
Balance SheetAdequate
Cash FlowBurning
Top Statement Risk

Persistent Operating Margin Deficit

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Recovery Amidst Cyclical Rebound

According to quarterly financial data, Silicon Laboratories has demonstrated a significant revenue recovery, with year-over-year growth reaching 20.1% in 2026Q1, marking a sharp reversal from the contractionary environment observed throughout 2024, as the company successfully navigates the post-inventory correction phase of the semiconductor cycle.

The recent acceleration in top-line performance suggests that the company's IoT-focused strategy is gaining traction as channel inventory levels normalize. However, investors should monitor whether this growth is sustainable or merely a reflection of pent-up demand following the severe revenue declines experienced in early 2024.

Gross Margin Resilience Despite Scale

As reported in recent income statements, Silicon Laboratories has maintained a gross margin of 56.7% in 2026Q1, which underscores the premium pricing power inherent in its specialized mixed-signal and wireless microcontroller portfolio despite the broader volatility currently impacting the semiconductor industry's pricing environment.

The ability to sustain gross margins above 55% even during periods of significant revenue fluctuation suggests that the company's proprietary software-defined hardware creates a meaningful competitive moat. This pricing power appears to be a critical buffer, though it has yet to translate into positive operating profitability.

Operating Leverage Constrained by R&D

Based on the provided income statement figures, Silicon Laboratories continues to struggle with operating leverage, as R&D expenses of $82.5 million in 2026Q1 remain disproportionately high relative to revenue, preventing the company from achieving the necessary scale to reach positive operating income levels.

The persistent operating loss of $5.9 million in the most recent quarter indicates that the company's fixed cost base, particularly in engineering talent, is currently misaligned with its revenue scale. Management appears to be prioritizing long-term technical leadership over immediate profitability, which warrants further investigation into the timeline for margin expansion.

Stock-Based Compensation Masks Cash Burn

Analysis of recent filings reveals that stock-based compensation remains a significant non-cash expense, totaling $21.1 million in 2026Q1, which effectively obscures the true extent of the company's cash-burn rate during this period of negative net income and ongoing operational restructuring.

The reliance on equity-based incentives to retain specialized engineering talent is a common industry practice, yet it complicates the assessment of the company's underlying cash-generating capability. Investors should be cautious, as these non-cash charges may be masking the severity of the current operating losses.

Structural Risks to Profitability Targets

While the company's revenue trajectory is improving, the persistent negative operating margin of -2.8% in 2026Q1 suggests that the firm may face structural challenges in achieving profitability, potentially leading to continued margin compression if competitive pressures from larger semiconductor peers intensify in the IoT space.

Short-term observers may focus on the inability to convert top-line growth into bottom-line results, which could indicate that the company's R&D-heavy model is becoming increasingly expensive to maintain. The risk remains that the company may be forced to choose between sacrificing its technical moat or accepting prolonged periods of financial underperformance.

SLAB — Frequently Asked Questions

Quick answers to the most common questions about buying SLAB stock.

What was Silicon Laboratories Inc.'s (SLAB) revenue in 2025?

For fiscal year 2025, Silicon Laboratories Inc. (SLAB) reported total revenue of $784.8M. This represents a 1573.3% increase compared to $46.9M in 1999.

Is Silicon Laboratories Inc. (SLAB) profitable?

Silicon Laboratories Inc. (SLAB) reported a net loss of $64.9M for the fiscal year ending 2025.

What is Silicon Laboratories Inc.'s operating profit margin?

Silicon Laboratories Inc. (SLAB) reported an operating income of $-70.5M, resulting in an operating profit margin of -9.0%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Silicon Laboratories Inc.'s gross profit and gross margin?

Silicon Laboratories Inc. (SLAB) generated $457.0M in gross profit for the year, representing a gross profit margin of 58.2%. This demonstrates the company's core pricing power and production efficiency.